Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study

Although infliximab is approved for psoriasis, its efficacy is reduced over time in some patients. The aim of this phase III trial is to evaluate efficacy and safety of infliximab dose escalation in Japanese psoriasis patients with loss of efficacy to standard‐dose therapy. Patients with plaque psor...

Descripción completa

Detalles Bibliográficos
Autores principales: Torii, Hideshi, Nakano, Masayuki, Yano, Toshiro, Kondo, Kazuoki, Nakagawa, Hidemi, Fujita, Yasuyuki, Horie, Keita, Ito, Miki, Iitani, Mari, Ito, Kei, Kaneko, Takahide, Akasaka, Toshihide, Ohtuki, Mamitaro, Yasuda, Masato, Abe, Masatoshi, Tanida, Yurika, Terui, Tadashi, Arai, Satoru, Nakano, Toshiaki, Etoh, Takafumi, Asano, Yoshihide, Umezawa, Yoshinori, Saeki, Hidehisa, Adachi, Makoto, Seishima, Mariko, Tokura, Yoshiki, Morita, Akimichi, Yamanaka, Keiichi, Tani, Mamoru, Tanimura, Hirotsugu, Yamazaki, Fumikazu, Nishigori, Chikako, Kaneko, Sakae, Muto, Masahiko, Nakamura, Motonobu, Hino, Ryosuke, Nakayama, Juichiro, Nakano, Teruaki, Utani, Atsushi, Sato, Toshihiro, Ihn, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434916/
https://www.ncbi.nlm.nih.gov/pubmed/27882586
http://dx.doi.org/10.1111/1346-8138.13698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434916/
https://www.ncbi.nlm.nih.gov/pubmed/27882586
http://dx.doi.org/10.1111/1346-8138.13698

Ejemplares similares